Try our beta test site
2 studies found for:    23305732 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting UARK 2006-66, Total Therapy 3B: An Extension of UARK 2003-33 Total Therapy
Condition: Multiple Myeloma
Interventions: Drug: Velcade;   Drug: Thalidomide;   Drug: Dexamethasone;   Drug: Adriamycin;   Drug: Cisplatin;   Drug: Cyclophosphamide;   Drug: Etoposide
2 Completed
Has Results
UARK 2003-33, Total Therapy III
Condition: Multiple Myeloma
Interventions: Drug: Velcade;   Drug: Thalidomide

Study has passed its completion date and status has not been verified in more than two years.